GSK
Live / Applied — Statement of use — non-final action mailed (as of 10 Oct 2026)
What this means for you
Not registered yet, but its 07 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97446090
- Mark type
- Design + words
- Filed
- 07 Jun 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation; Pharmaceutical preparations for the treatment of viral, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes.
- Class 035 — Advertising and business services: Advertising, marketing and promotional services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; the provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, healthcare products through an on-line computer network; distribution of advertising, marketing and promotional material.
- Class 041 — Education and entertainment services: Educational services, namely, conducting classes in the field of pharmaceutical, diagnostic, vaccines, proprietary medicines, health, medical and skin care industries; educational services, namely, conducting seminars regarding health and health awareness and distributing course material in connection therewith; conducting, organizing and arranging conferences, seminars and exhibitions for educational purposes in the field of medicine, health and wellness; publication of documents recorded on electronic storage media and on the internet in the field of scientific, medical diagnostic and technical laboratory matters and for research; training in the operation of scientific, surgical and medical devices and apparatus; publishing and issuing of scientific papers in the field of pharmaceuticals, diagnostic, vaccines, proprietary medicines, health, medical and skin care; provision of information, consultancy and advisory services relating to any of the aforesaid services.
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the field of pharmaceuticals, vaccines; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; scientific research consulting; medical laboratory services; Providing medical and scientific research information; medical and pharmacological research services; software development, programming and implementation; provision of information, consultancy and advisory services relating to any of the aforesaid services.
- Class 044 — Medical, beauty and agricultural services: Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; provision of information, consultancy and advisory services relating to any of the aforesaid services
Owner
- SmithKline Beecham Limited, London, GB
- SmithKline Beecham Limited, Brentford, Middlesex, GB
Board proceedings on this mark
- Extension of Time to Oppose No. 97446090 — Vericel Corporation v. SmithKline Beecham Limited, filed 18 Aug 2023 (Terminated)
Prosecution history
- 10 Oct 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Oct 2026 — NON-FINAL ACTION E-MAILED
- 10 Oct 2026 — SU - NON-FINAL ACTION - WRITTEN
- 08 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Aug 2026 — USE AMENDMENT FILED
- 11 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2026 — SOU EXTENSION 4 GRANTED
- 06 Mar 2026 — SOU EXTENSION 4 FILED
- 06 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 3 GRANTED
- 10 Sept 2025 — SOU EXTENSION 3 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED